Barclays’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $5.14M | Buy |
|
|||||
|
2020
Q4 | $196K | Sell |
|
|||||
|
2020
Q3 | $973K | Buy |
|
|||||
|
2020
Q2 | $117K | Sell |
|
|||||
|
2020
Q1 | $50K | Sell |
|
|||||
|
2019
Q4 | $209K | Buy |
|
|||||
|
2019
Q3 | $121K | Sell |
|
|||||
|
2019
Q2 | $201K | Buy |
|
|||||
|
2019
Q1 | $294K | Buy |
|
|||||
|
2018
Q4 | $147K | Sell |
|
|||||
|
2018
Q3 | $534K | Buy |
|
|||||
|
2018
Q2 | $75K | Sell |
|
|||||
|
2018
Q1 | $437K | Buy |
|
|||||
|
2017
Q4 | $154K | Sell |
|
|||||
|
2017
Q3 | $413K | Buy |
|
|||||
|
2017
Q2 | $278K | Sell |
|
|||||
|
2017
Q1 | $562K | Buy |
|
|||||
|
2016
Q4 | $385K | Buy |
|
|||||
|
2016
Q3 | $261K | Buy |
|
|||||
|
2016
Q2 | $91K | Sell |
|
|||||
|
2016
Q1 | $2.72M | Buy |
|
|||||
|
2015
Q4 | $1.75M | Buy |
|
|||||
|
2015
Q3 | $172K | Buy |
|
|||||
|
2015
Q2 | $118K | Buy |
|
|||||
|
2015
Q1 | $23K | Buy |
|
|||||
|
2014
Q4 | $27K | Buy |
|
|||||
|
2014
Q3 | $6K | Buy |
|
|||||
|
2014
Q2 | $5K | Sell |
|
|||||
|
2014
Q1 | $7K | Buy |
|
|||||
|
2013
Q4 | $1K | Buy |
|